Your account is not claimed yet. You can sign up with ORCID to claim your account.

Peter Jepsen

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 28

Top Venues

Hepatology communications

Clinical epidemiology

Liver international : official journal of the International Association for the Study of the Liver

Alimentary pharmacology & therapeutics

Aarhus University Hospital

Aarhus University, HEALTH (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus University Hospital Dec 1o 2016

Denmark

Specialist in hepatology ("afdelingslæge") :: Department of Hepatology and Gastroenterology

Education History

Aarhus University, HEALTH

Denmark

PHD

Publications

Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen, Marlene Christina Nielsen, Astrid Højmark Andersen, Peter Ott, Sabine Becker, Henning Glerup, Lise Svenningsen, Martin Eivindson, Linda Kornerup, Niels Bjørndal Kjeldsen, Anders Neumann, Holger Jon Møller, Peter Jepsen, Henning Grønbæk
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis. Hepatology communications 7 (4) (2023)
Morten Daniel Jensen, Hugh Watson, Hendrik Vilstrup, Peter Jepsen
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study. Clinical epidemiology 15 (2023)
Marine Sølling Ramsing, Frederik Kraglund, Peter Jepsen
Prevalence of Statin Use and Predictors of Statin Initiation Among Patients with Alcohol-Related Cirrhosis - A Danish Nationwide Cohort Study. Clinical epidemiology 15 (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda E Villadsen, Joe West, Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen, Marlene Christina Nielsen, Astrid Højmark Andersen, Peter Ott, Sabine Becker, Henning Glerup, Lise Svenningsen, Martin Eivindson, Linda Kornerup, Niels Bjørndal Kjeldsen, Anders Neumann, Holger Jon Møller, Peter Jepsen, Henning Grønbæk
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis. Hepatology communications 7 (4) (2023)
Frederik Kraglund, Gerda Elisabeth Villadsen, Peter Jepsen
Effects of Curative-Intent Treatments on Hepatocellular Carcinoma Survival in Alcohol-Related Cirrhosis: A Nationwide Study. Clinical epidemiology 15 (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda E Villadsen, Joe West, Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda E Villadsen, Joe West, Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen, Marlene Christina Nielsen, Astrid Højmark Andersen, Peter Ott, Sabine Becker, Henning Glerup, Lise Svenningsen, Martin Eivindson, Linda Kornerup, Niels Bjørndal Kjeldsen, Anders Neumann, Holger Jon Møller, Peter Jepsen, Henning Grønbæk
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis. Hepatology communications 7 (4) (2023)
Morten Daniel Jensen, Hugh Watson, Hendrik Vilstrup, Peter Jepsen
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study. Clinical epidemiology 15 (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda E Villadsen, Joe West, Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Frederik Kraglund, Gerda Elisabeth Villadsen, Peter Jepsen
Effects of Curative-Intent Treatments on Hepatocellular Carcinoma Survival in Alcohol-Related Cirrhosis: A Nationwide Study. Clinical epidemiology 15 (2023)
Frederik Kraglund, Diana Hedevang Christensen, Andreas Halgreen Eiset, Gerda E Villadsen, Joe West, Peter Jepsen
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. Hepatology communications 7 (1) (2023)
Rasmus Hvidbjerg Gantzel, Niels Kristian Aagaard, Hendrik Vilstrup, Hugh Watson, Henning Grønbæk, Peter Jepsen
Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality. Hepatology communications 6 (11) (2022)
Weiqi Liao, Peter Jepsen, Carol Coupland, Hamish Innes, Philippa C Matthews, Cori Campbell, Eleanor Barnes, Julia Hippisley-Cox, null null
Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch® database: research protocol and statistical analysis plan. Diagnostic and prognostic research 6 (1) (2022)
Andreas Ladefoged Ebbehøj, Esben Søndergaard, Peter Jepsen, Kirstine Stochholm, Helene Matilde Lundsgaard Svane, Morten Madsen, Per Løgstrup Poulsen, Jens Otto Lunde Jørgensen
The Socioeconomic Consequences of Cushing's Syndrome: A Nationwide Cohort Study. The Journal of clinical endocrinology and metabolism 107 (7) (2022)
Rasmine Birn-Rydder, Morten Daniel Jensen, Peter Jepsen, Lisbet Grønbaek
Extrahepatic autoimmune diseases in autoimmune hepatitis: Effect on mortality. Liver international : official journal of the International Association for the Study of the Liver 42 (11) (2022)
Peter Jepsen, Elliot B Tapper, Thomas Deleuran, Konstantin Kazankov, Gro Askgaard, Henrik Toft Sørensen, Hendrik Vilstrup, Joe West
Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation-wide Cohort Study. Hepatology (Baltimore, Md.) 74 (5) (2021)
Frederik Kraglund, Thomas Deleuran, Gro Askgaard, Kate M Fleming, Peter Jepsen
Decreasing Incidence of Alcohol-Related Liver Disease in Denmark: A 25-Year Nationwide Study. Clinical epidemiology 13 (2021)
Lars Bossen, Paola Rebora, Francesca Bernuzzi, Peter Jepsen, Alessio Gerussi, Pietro Andreone, Andrea Galli, Benedetta Terziroli, Domenico Alvaro, Giancarlo Labbadia, Chiara Aloise, Leonardo Baiocchi, Edoardo Giannini, Ludovico Abenavoli, Pierluigi Toniutto, Fabio Marra, Marco Marzioni, Grazia Niro, Annarosa Floreani, Holger J Møller, Maria G Valsecchi, Marco Carbone, Henning Grønbaek, Invernizzi Pietro
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Lisbet Grønbaek, Harmony Otete, Lu Ban, Colin Crooks, Timothy Card, Peter Jepsen, Joe West
Incidence, prevalence and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study. Liver international : official journal of the International Association for the Study of the Liver 40 (7) (2020)
Peter Jepsen, Hugh Watson, Stewart Macdonald, Hendrik Vilstrup, Rajiv Jalan
MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites. Alimentary pharmacology & therapeutics 52 (3) (2020)
Morten Daniel Jensen, Torsten Lauritzen, Hendrik Vilstrup, Peter Jepsen
Alanine Aminotransferase and 20-Year Risk of Major Chronic Diseases and Death in a Healthy Cohort Aged 30 to 49 Years. Clinical epidemiology 12 (2020)
Lisbet Grønbaek, Hendrik Vilstrup, Peter Jepsen
Editorial: severe outcomes are rare in pregnancy in autoimmune hepatitis-Authors' reply. Alimentary pharmacology & therapeutics 48 (9) (2019)
Gitte Dam, Hendrik Vilstrup, Per Kragh Andersen, Lars Bossen, Hugh Watson, Peter Jepsen
Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites. Liver international : official journal of the International Association for the Study of the Liver 39 (3) (2018)
Lisbet Grønbaek, Hendrik Vilstrup, Lars Pedersen, Peter Jepsen
Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study. Liver international : official journal of the International Association for the Study of the Liver 39 (1) (2018)
Stewart Macdonald, Peter Jepsen, Laith Alrubaiy, Hugh Watson, Hendrik Vilstrup, Rajiv Jalan
Quality of life measures predict mortality in patients with cirrhosis and severe ascites. Alimentary pharmacology & therapeutics 49 (3) (2018)
Peter Jepsen, Jakob Christensen, Karin Weissenborn, Hugh Watson, Hendrik Vilstrup
Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study. BMC gastroenterology 16 (1) (2016)

Peter Jepsen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Jepsen